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INTRODUCTION
Concepts of surgical wound infection and the prevention of infection have been known 
to mankind from time immemorial.  
Sushrutha, the father of Indian Surgery compiled the knowledge of surgery of his day 
and age in his classic Sushrutha Samhita.  He laid emphasis on clean surgical technique.
The Egyptians’ medical papyrus describes the use of salves and antiseptic to prevent 
wound infection.
Hippocratic techniques in  ancient Greece established the use of wine and vinegar to 
irrigate open wounds before successful secondary closure.
More recently, however in 1553, Anton von Leeuwenhoek, an Austrian physician first 
discovered bacteria through the microscope, which had just been invented.
Before the 19th Century, it was common to have post-op “irritative fever” followed by 
purulent drainage overwhelming sepsis and often death.
Luis Pasteur in 1857 discovered and explained the process of fermentation by micro-
organisms.
Semmelweis,  an  Austrian  physician was a fervent advocate of hand washing but in 
those days, people were so averse to such “crazy” ideas that he was shot and killed by his  
colleagues who were not too eager to bear the “nuisance”.
In the late 1860s, Joseph Lister introduced principles of antisepsis.  This led to a drastic 
reduction in post-operative infections and mortality.
Caspar Stromayar in 1880 brought the attention of his colleagues to the importance of 
pre-operative baths and shaving of the body parts of patients.
The famous postulates of Koch regarding infection were postulated in 1884.   This led 
to a radical change in the way people understood infection.
Halsted is widely regarded as the father of Modern Surgery.  One among his myriad 
contributions to surgery was the use of gloves in 1890.
Meleny, who has given his name to a specific ulcer, described the pathophysiology of 
necrotising fasciitis in 1924.
Alexander  Fleming’s  famous  discovery  of  penicillin came  about  in  1929 and 
antibiotics have revolutionised medical science since.
The first cephalosporin was discovered 57 years ago in 1948.   There have been five 
generations of cephalosporins since then and the fifth generation drugs of the 21 st century act 
against practically all the bacteria present on earth today.
The  early  60’s saw  the  synthesis  of  quinolones and  Gentamicin,  two  more  path 
breakers along the long winding route that antimicrobial therapy has travelled till date.
Still,  wound infections continue to be a menace despite significant improvements in 
antibiotics, improved anaesthesia, superior instruments, vastly improve concepts of disinfecting 
and  sterilization,  earlier  diagnosis  of  surgical  problems  of  improved  techniques  for  post-
operative vigilance.
The problem can have a wide spectrum of effects on the patient, ranging from cosmetic 
disfigurement to prolonged hospital stay to even increased post-operative mortality.
DEFINITIONS
The surgical wound encompasses that area of the body both internally and externally 
that  involves  the  entire  operative  site.   Wounds  are  thus  categorized  into  three  general 
categories.
Superficial – Including skin and subcutaneous tissue
Deep – Including deep fascia and muscle
Organ space – Including internal organs of the body.
1. Wound infections
Wound infections are technically referred to as  surgical site infections (SSIs) by the 
centres for  Disease control  and prevention at  Atlanta.  The CDC has  laid out  very  specific 
criteria for diagnosis of both superficial and deep SSIs.
Superficial incisional SSIs
 Infection less than 30 days after operation
 Involves only the skin and subcutaneous tissue of incision plus at least one of the following.
o Purulent drainage with or without laboratory confirmation of infection
o Organisms isolated from on aseptically obtained culture of fluid or tissue from 
the incision.
o At least one of the following signs and symptoms
 Pain or tenderness at site
 Localised swelling, redness or warmth
 Superficial incision deliberately opened by surgeon.
o Diagnosis of SSI by the attending surgeon or physician
The following are not to be reported as superficial incisional SSIs.
 Stitch abscess
 Infection of episiotomy or circumcision in newborn.
 Infected burn wounds
 Superficial incision, which on opening yields culture-negative fluid. 
 Deep Incisional SSIs
 Infection less than 30 days after operation with no implant and soft tissue involvement.
 Infection less than 1 year after operation with implant.
 Infection involves deep soft tissues (deep fascia and muscle) plus at least one of the 
following.
o Purulent drainage from deep space but not extending into organ space.
o Abscess  found in the  deep space on direct  or  radiological  examination or  on 
reoperation.
o Diagnosis of a deep space SSI by surgeon
o Symptoms of fever, pain and tenderness lead to dehiscence of wound or opening 
by a surgeon.
Organ Space SSIs
 Infection less than 30 days after surgery with no implant.
 Infection less than 1 year after surgery with implant and infection, involving any part of 
the anatomy (organ/organ space) opened or manipulated during operation plus at least 1 of 
the following.
o Purulent drainage from a drain placed through a slab wound into the space.
o Organisms +ve in aseptically attained culture of fluids or tissue from the organ 
space.
o Abscess of the organ space.
o Diagnosis of an organ space SSI by the attending surgeon or physician.
2. Surgical wounds:
Surgical  wounds have been classified  according to  the  relative  risk of  postoperative 
wound infection occurring. The four categories are as below:
1) Clean wound 
a. No hollow viscus entered
b. No body cavities (pleural, abdominal, joint) entered
c. No inflammation
d. No breaks in aseptic technique
e. Elective procedure
f. Primary wound closure
2) Clean contaminated
a. Hollow viscus or body cavity entered but controlled
b. No inflammation
c. Primary closure
d. Minor breaks in aseptic technique
e. Mechanical drain used
f. Pre-operative bowel preparation done
3) Contaminated
a. Uncontrolled spillage from viscus
b. Inflammation apparent
c. Open, traumatic wound
d. Major break in aseptic technique
4) Dirty
.a Untreated, uncontrolled spillage from viscus
.b Pus in operative wound
.c Open suppurative wound
.d Severe inflammation.
Wound infections obviously occur because of bacterial contamination of the surgical 
site. Although bacterial contamination can occur in many ways, the most common source of 
superficial SSIs is the bacterial flora from surrounding skin.
SSIs, with their multitude of causative factors, can be dealt with in various ways, one of 
the important ways being antibiotic prophylaxis.
3. Antibiotic prophylaxis with respect to time of administration:
  There have been attempts to determine the optimum duration of time before surgery 
when antibiotic prophylaxis seems to work best.
Early prophylaxis – 24 hrs – 2 hrs prior to surgery.
Pre-operative prophylaxis – within 2 hrs prior to surgery
Perioperative prophylaxis – within 3 hrs after incision
Postoperative prophylaxis – 3 – 24 hrs after incision.
It is with a background of these concepts that literature on the subject of surgical site 
infections was reviewed.
REVIEW OF LITERATURE
1) Balthazar et al reported in July 1982 about pre-operative skin preparation with respect 
to hair removal. 200 patients undergoing inguinal herniorrhaphy were studied.  They found 
out that clipping significantly reduced the risk of SSIs as opposed to shaving.
2) Olson MM et al did a similar study in  Feb. 1986. A survey of wound infection rates 
among 4580 patients was done. There was no significant change in wound infection rates 
whether hair was shared or clipped.
3) Dipiro J et al  made a few observations about single dose antibiotic prophylaxis  for 
surgical  wound  infections.   Studies  compared  single  dose  Vs  placebo,  single  dose  Vs 
multiple dose of the same agent, single doses of various antibiotics and single dose of one 
agent  Vs  multiple  doses  of  a  different  drug.   A  single  dose  of  antibiotics,  usually 
cephalosporins, given immediately before surgery was found to be the most effective in 
preventing  wound  infections  in  gastric  surgeries,  biliary  procedures,  transurethral 
operations, hysterectomies and caesarean sections.
4) Classen D C et al, in January 1992, studied the appropriate timing of administration of 
prophylactic antibiotics that was required for optimum prevention of SSIs. 
They classified the time of administration of antibiotics with respect to surgery into early 
(24 hrs – 2 hrs pre-op), pre-operative, perioperative (within 3 hours after incision) and post-
operative (3-24 hours post-incision) prophylaxis.  Rates of SSIs were found to be least in 
when the drug was given pre-operatively.
5) Greif  R et  al  of  Vienna,  Austria  in  January  1992 studied  incidence  of  SSIs  after 
supplemental perioperative oxygen. Patients were given either 60% O2 or 30% O2. The rate 
of SSIs was lower in those given 60% oxygen.
6) Dellinger and  colleagues  found  out  that  diabetes  mellitus  and  postoperative 
hyperglycaemia were independently associated with an increased risk of SSIs.
7) Joan Robinson and Colleagues from Edmonton in Canada reported in 2002 about the 
practical aspects of choosing an antibiotic for patients with reported allergy to drugs.
If penicillin allergy is present, likelihood of cross reactivity to cephalosporins increases 2 – 
fold. However, with a third generation cephalosporin, that risk is lower than the risk with 
other alternatives.
8) Melling A C et al reported the effects of normothermia and pre-operative warming on 
the incidence of SSIs after clean surgery after a randomized control trial. Warming and the 
normothermia that was produced as a result was found to lower risk of SSIs.
9) Dale  Bratzler &  Peter  M  Houck have  reviewed  on  advisory  statement  from  the 
National Surgical Infection Prevention Project in the Journal of Clinical Infectious Diseases, 
2004.
According to them, SSIs are the second most common cause of nosocomial infections.
Some recommendations of the project have been reviewed:
 The goal of preoperative prophylaxis is to achieve serum and tissue drug levels that 
exceed the minimum inhibitory concentration of the drug for the organisms most likely 
to infect the wound.  Ideally, the drug has to be administered as near to incision time as 
possible - usually within 60 min before incision.
 Prophylaxis after wound closure unnecessary, since most studies show no benefit.
 While  screening  patients  for  beta-lactam  allergy,  proper  history  of  previous  drug 
reactions like hypersensitivity, fever and Toxic Epidermal Necrolysis has to be taken. 
Also, past history of allergy, urticaria, bronchospasm, arrhythmias, hypotension, has to 
be taken.
 In  patients  with  penicillin  allergy,  cephalosporins  are  the  appropriate  alternate 
antibiotics, since cephalosporin allergy is very rare even in cases of penicillin allergy.
10) The Department of surgery at University of Washington, Seattle, brought out a report 
on  SSIs.   44  hospitals,  which  recorded  data  on  35,543  surgical  cases,  reported  a 
reduction in rates of SSIs associated with appropriate antibiotics selection timing and 
duration of prophylaxis  normothermia,  oxygenation, euglycemia and appropriate hair 
removal.
11) Kurz A and colleagues from San Francisco have studied the effect of perioperative 
hypothermia and normothermia on wound healing and SSIs.  Hypothermia will lead to 
thermoregulatory  vasoconstriction.  This  causes  reduced  oxygenation  of  tissues  and 
oxidative  killing  by  neutrophils.  The  study  revealed  a  significant  increase  in  the 
incidence of SSIs in the hypothermic patients.
12) Kirkland KB &  Briggs JP from  Duke University  Medical  Centre studied the 
impact of SSIs attributable to mortality, excess length of hospitalization and extra costs.  
They  found  that  the  extra  hospital  stay  attributable  to  SSIs  was  1  week.  Also, 
postoperative mortality in-patient who had SSIs was twice that of those who didn’t.
13) Another study of pre-operative antibiotics prophylaxis for herniorrhaphy and breast 
surgery reveals that rate of SSIs is halved by giving the prophylaxis.
14) Bennett S N et al published a report in the New England Journal of Medicine in July 
1995. Between June 1990 and February 1993, the CDC conducted investigations at 7 
hospitals because of unusual outbreaks of bloodstream infections, SSIs and acute febrile 
episodes after surgical procedures. Exposure to Propofol, a lipid-based anaesthetic agent 
was found to be significantly associated with the development of SSIs. Interviews with 
and observation of the anaesthesiology personnel revealed a wide variety of lapses in 
aseptic techniques. 
15) Nichols R L, in his article in the American Journal of Medicine in 1984, showed that 
the pathogens most frequently isolated from the infected wounds were polymicrobial 
aerobic  and  anaerobic  flora  that  closely  resembled  the  endogenous  microflora  that 
normally inhabited the resected organ. 
16) Burke J F et al reported about the effective period of preventive antibiotic action in 
experimental  incisions  and  dermal  lesions  in  1961.  To  greatly  reduce  the  infection 
caused by penicillin-sensitive Staphylococcus aureus, the penicillin had to be in the skin 
shortly before or at the time of the incision and bacterial exposure. This brought to light 
the perils of administering the first dose of antibiotic in the postoperative recovery room. 
17) Platt R et al reported on the efficacy of perioperative antibiotics for herniorrhaphy 
and  breast  surgery  in  1990.  A randomized  controlled  trial  was  conducted  on  1218 
patients  undergoing  surgery  for  inguinal  hernias  and  pathological  conditions  of  the 
breast  including  excision  of  breast  mass,  mastectomy,  reduction  mammoplasty  and 
axillary node dissection. 
A single dose of 1g of Cefonicid was given intravenously approximately 30 minutes 
before  surgery.  The  patients  who  received  prophylaxis  had  48% fewer  probable  or 
definite infections compared to those who didn’t receive the prophylactic dose.
18) Ko W et al have reported in 1992 about a study to investigate the effects of hair removal 
methods on the incidence of SSIs. Nearly 2000 patients  undergoing thoracic surgery 
were randomised to manual shaving Vs electrical clipping of hair before the incision. 
The infection rate was significantly high in the manually shaved group.
18) Lazenby W D et al have reported on the practice of irrigation of wounds just before 
closure and the effect on infection rate. Patients were irrigated with saline or povidone 
iodine solution just before closing the wound. The patients irrigated with saline had a 
significantly lower rate of infection.
18) Burke J P et al have reported in 2001 regarding errors in antimicrobial prophylaxis for 
surgical  patients.  Failure  to  administer  the  drug  within  the  2-hour  window prior  to 
incision is associat4ed with a 2- to 6-fold increase in rates of SSIs.
18) Karen L. Stierman and Ronald W. Deskin, in their review of antibiotics in head and 
neck  surgery  have  classified  wounds  into  four  classes  based  on  the  guidelines  for 
prevention of SSIs. 
Class I - Clean wounds
Class II - Clean – contaminated wounds
Class III - Contaminated wounds
Class IV - Dirty wounds
However, the most extensive single body of literature on surgical site infections consists 
of  the  guidelines  for  prevention  of  SSIs  published  by  the  centre  for  disease  control  and 
prevention (CDC), based in Atlanta, Georgia in U.S.A.
Apart  from the definition of SSIs and criteria for diagnosis,  there are guidelines for 
inclusion and exclusion criteria’s information about the microbiology of SSIs, the pathogenesis, 
the  risk  factors,  the  guidelines  for  prevention  of  SSIs  and  the  principles  of  antimicrobial 
prophylaxis against SSIs.
Microbiology and pathogenesis:
The most frequent pathogens incriminated in surgical site infections are Staphylococcus 
aureus, coagulase –ve Staphylococci, Enterococci and Escherichia coli, all primarily aerobic in 
nature.
Multidrug resistant Staphylococcus aureus (MRSA) and Candida are now on the rise. 
Pathogens like Clostridium perfringens and Rhizopus are unusual.
A minimal degree of microbial contamination is necessary for an SSI to set in.
Dose of contaminant x Virulence of organisms
Risk of SSI = ----------------------------------------------------------
Resistance of the host
Quantitatively, the risk is very high if dose is more than 106 organisms per gram of 
tissue.
In most cases of SSI, the pathogens are endogenous flora on the patient’s body – on the 
skin, mucous membranes and in hollow viscera.
However,  pathogens  of  SSIs  also  have  exogenous  sources  like  surgical  personnel, 
operating room environment, including the air, the tools, instrument and materials brought to 
the sterile field during the surgery, etc.
Risk factors
The term risk factor has a particular meaning in epidemiology and, in the context of SSI 
pathophysiology and prevention, strictly refers to a variable that has a significant independent 
association with the development of SSI after a specific operation.
The various risk factors have been classified into patient – dependent and operation – 
dependent factors, as shown in the table below.
Patient – dependent risk factors:                                                             
 Advanced age
 Diabetes mellitus
 Nicotine use
 Steroid usage
 Nutritional status – malnutrition
 Prolonged pre-operative hospital stay
 Pre-operative colonization of nares with Staph. aureus.
 Perioperative transfusion leading to altered immune response
 Obesity
__________________________________________________________
Operation-dependent risk factors:
 Duration of scrub
 Skin antisepsis
 Pre-operative skin preparation
 Duration of operation
 Antimicrobial prophylaxis
 Operating room ventilation
 Sterilization of instruments
 Foreign material in surgical site
 Drain placement
 Technique of operation – 
o Poor Haemostasis
o Failure to obliterate dead space, etc.
o Tissue trauma.
Patient Characteristics 
In  certain  kinds  of  operations,  patient  characteristics  possibly  associated  with  an 
increased risk of an SSI include coincident remote site infections or colonization, diabetes, 
cigarette smoking, systemic steroid use, obesity (>120% of ideal body weight), extremes of age, 
poor nutritional status and perioperative transfusion of certain blood products.
a. Diabetes 
Recent preliminary findings from a study of patients who underwent coronary artery 
bypass  graft  showed  a  significant  relationship  between  increasing  levels  of  glycosylated 
haemoglobin  and SSI  rates.  Also,  increased  glucose  levels  (>200  mg/dL)  in  the  immediate 
postoperative period (<48 hours) were associated with increased SSI risk. 
b. Nicotine use 
Nicotine use delays primary wound healing and may increase the risk of SSI. In a large 
prospective study, current cigarette smoking was an independent risk factor for sternal and/or 
mediastinal SSI following cardiac surgery. Other studies have corroborated cigarette smoking 
as an important SSI risk factor. 
c. Steroid use 
Patients who are receiving steroids or other immunosuppressive drugs preoperatively 
may be predisposed to developing SSIs. In a study of long-term steroid use in patients with 
Crohn's  disease,  SSI  developed  significantly  more  often  in  patients  receiving  preoperative 
steroids (12.5%) than in patients without steroid use (6.7%). In contrast, other investigations have 
not found a relationship between steroid use and SSI risk. 
d. Malnutrition
For some types of operations, severe protein-calorie malnutrition is crudely associated 
with post-operative nosocomial infections, impaired wound healing dynamics or death. 
Theoretical arguments can be made for a belief that severe preoperative malnutrition 
should increase the risk of both incisional  and organ-space SSIs.  Preoperative malnutrition 
causes  impairment  in  protein  synthesis  and therefore  impairment  in  the  process  of  wound 
healing and repair, thus increasing the chances of infection of the wound.
In the modern era total parenteral nutrition (TPN) and total enteral alimentation (TEA) 
have enthusiastic acceptance by surgeons and critical care specialists.  However, the benefits of 
preoperative nutritional repletion of malnourished patients in reducing SSI risk are unproven. 
This inability to prove that nutritional support  reduces infection-related risk is therefore an 
indirect evidence of the high risk of SSI associated with malnutrition.
e. Prolonged preoperative hospital stay
Prolonged preoperative hospital stay is frequently suggested as a patient characteristic 
associated with increased SSI risk. However, length of preoperative stay is likely a surrogate 
for severity of illness and co-morbid conditions requiring inpatient work-up and/or therapy 
before the operation. 
f. Preoperative nares colonization with Staph. aureus
S. aureus is a frequent SSI isolate. This pathogen is carried in the nares of 20% to 30% of 
healthy humans. It has been known for years that the development of SSI involving S. aureus is 
definitely associated with preoperative nares carriage of the organism in surgical patients. A 
recent  multivariate  analysis  demonstrated  that  such  carriage  was  the  most  powerful 
independent risk factor for SSI following cardiothoracic operations. 
Mupirocin ointment is effective as a topical agent for eradicating S.  aureus  from the 
nares of colonized patients or healthcare workers. A prospective, randomized clinical trial has 
recently been completed on patients in Iowa. Five types of operations in two facilities were 
observed. Preliminary analysis showed a significant association between nasal carriage of S. 
aureus and subsequent SSI development. The effect of mupirocin on reducing SSI risk is yet to 
be determined. 
g. Perioperative transfusion 
It  has been reported that perioperative transfusion of leukocyte-containing allogeneic 
blood components is an apparent risk factor for the development of postoperative bacterial 
infections, including SSI. In three of five randomized trials conducted in patients undergoing 
elective colon resection for cancer, the risk of SSI was at least doubled in patients receiving 
blood transfusions. However, on the basis of detailed epidemiologic reconsiderations, there is  
currently no scientific basis for withholding necessary blood products from surgical patients as 
a means of either incisional or organ/ space SSI risk reduction. 
Operative Characteristics: Preoperative Issues 
a. Preoperative antiseptic showering 
A preoperative antiseptic shower or bath decreases skin microbial colony counts. In a 
study  of  more  than  700  patients  who  received  two  preoperative  antiseptic  showers, 
chlorhexidine reduced bacterial colony counts nine fold, while povidone-iodine reduced colony 
counts by 1.3 and 1.9 fold, respectively. Chlorhexidine gluconate-containing products require 
several applications to attain maximum antimicrobial benefit; so repeated antiseptic showers 
are usually indicated. Even though preoperative showers reduce the skin's microbial colony 
counts, they have not definitively been shown to reduce SSI rates. 
b. Preoperative hair removal 
Preoperative shaving of the surgical site the night before an operation is associated with 
a significantly higher SSI risk than either the use of depilatory agents or no hair removal. In 
one study, SSI rates were 5.6% in patients who had hair removed by razor shave compared to a 
0.6% rate among those who had hair removed by depilatory or who had no hair removed.  The 
increased SSI risk associated with shaving has been attributed to microscopic cuts in the skin 
that later serve as foci for bacterial multiplication. Shaving immediately before the operation 
compared to shaving within 24 hours preoperatively was associated with decreased SSI rates 
(3.1% vs. 7.1%); if shaving was performed more than 24 hours prior to operation, the SSI rate 
exceeded 20%. Clipping hair immediately before an operation also has been associated with a 
lower risk of SSI than shaving or clipping the night before an operation (SSI rates immediately 
before 1.8% vs. night before 4.0%). Although the use of depilatories has been associated with a 
lower  SSI  risk  than  shaving  or  clipping,  depilatories  sometimes  produce  hypersensitivity 
reactions. Other studies showed that preoperative hair removal by any means was associated 
with increased SSI rates and suggested that no hair be removed, 
c. Patient skin preparation in the operating room.
Several antiseptic agents are available for preoperative preparation of skin at the incision 
site.  The  iodophors  (e.g.,  povidone-iodine),  alcohol-containing  products,  and  chlorhexidine 
gluconate are the most commonly used agents. 
Alcohol is defined by the FDA as having one of the following active ingredients: ethyl 
alcohol, 60% to 95% by volume in an aqueous solution, or isopropyl alcohol, 50% to 91.3% by 
volume in an aqueous solution. Alcohol is readily available, inexpensive, and remains the most 
effective  and  rapid-acting  skin  antiseptic.  Aqueous  70%  to  92%  alcohol  solutions  have 
germicidal  activity  against  bacteria,  fungi,  and  viruses,  but  spores  can  be  resistant.   One 
potential disadvantage of the use of alcohol in the operating room is its flammability. 
Both  chlorhexidine  gluconate  and  iodophors  have  broad  spectra  of  antimicrobial 
activity.  In some comparisons of the two antiseptics when used as preoperative hand scrubs, 
chlorhexidine  gluconate  achieved  greater  reductions  in  skin  microflora  than  did  povidone-
iodine and also had greater residual activity after a single application.  Further, chlorhexidine 
gluconate is not inactivated by blood or serum proteins. Iodophors may be inactivated by blood 
or serum proteins, but exert a bacteriostatic effect as long as they are present on the skin. 
Before the skin preparation of a patient is initiated, the skin should be free of gross 
contamination (i.e., dirt, soil, or any other debris) . The patient's skin is prepared by applying an 
antiseptic in concentric circles, beginning in the area of the proposed incision. The prepared 
area should be large enough to extend the incision or create new incisions or drain sites, if 
necessary. The application of the skin preparation may need to be modified, depending on the 
condition of the skin (e.g., burns) or location of the incision site (e.g., face). 
There are reports of modifications to the procedure for preoperative skin preparation 
which include: 
(1) removing or wiping off the skin preparation antiseptic agent after application, 
(2) using an antiseptic-impregnated adhesive drape, 
(3) merely painting the skin with an antiseptic in lieu of the skin preparation procedure 
described above, or 
(4)  using a "clean" versus a "sterile" surgical skin preparation kit.  However,  none of 
these modifications has been shown to represent an advantage. 
d. Preoperative hand/forearm antisepsis 
Members of the surgical team who have direct contact with the sterile operating field or 
sterile instruments or supplies used in the field wash their hands and forearms by performing a  
traditional procedure known as scrubbing (or the surgical scrub) immediately before donning 
sterile  gowns and gloves. Ideally,  the optimum antiseptic used for the scrub should have a 
broad  spectrum  of  activity,  be  fast  acting,  and  have  a  persistent  effect.  Antiseptic  agents 
commercially available in the United States for this purpose contain alcohol, chlorhexidine, 
iodine/iodophors, parachloro-meta-xylenol, or triclosan.
Alcohol  is  considered  the  gold  standard  for  surgical  hand  preparation  in  several 
European countries. However, when 7.5%  povidone-iodine or  4%  chlorhexidine gluconate was 
compared to alcoholic chlorhexidine (60% isopropanol and 0.5% chlorhexidine gluconate in 70% 
isopropanol), alcoholic chlorhexidine was found to have greater residual antimicrobial activity, 
No agent is ideal for every situation, and a major factor, aside from the efficacy of any product, 
is  its  acceptability  by  operating room personnel  after  repeated use.  No clinical  trials  have 
evaluated the impact of scrub agent choice on SSI risk. 
Recent studies suggest that scrubbing for at least  2 minutes is as effective as the tradi-
tional l minute scrub in reducing hand bacterial colony counts, but the optimum duration of 
scrubbing  is  not  known.  The  first  scrub  of  the  day  should  include  a  thorough  cleaning 
underneath fingernails (usually with a brush). It is not clear that such cleaning is a necessary 
part of subsequent scrubs during the day. After performing the surgical scrub, hands should be 
kept up and away from the body (elbows in flexed position) so that water runs from the tips of 
the fingers toward the elbows. Sterile towels should be used for drying the hands and forearms 
before the donning of a sterile gown and gloves. 
A surgical team member who wears artificial nails may have increased bacterial and 
fungal colonization of the hands despite performing an adequate hand scrub. Hand carriage of 
gram-negative organisms has been shown to be greater among wearers of artificial nails than 
among  non-wearers.  An  outbreak  of  Serratia  marcescens  SSIs  in  cardiovascular  surgery 
patients was found to be associated with a surgical nurse who wore artificial nails. 
e. Management of infected or colonized surgical personnel 
Surgical  personnel  who  have  active  infections  or  are  colonized  with  certain  micro-
organisms have been linked to outbreaks or clusters of SSIs.  Thus, it is important that health 
care  organizations  implement  policies  to  prevent  transmission  of  micro-organisms  from 
personnel to patients. 
f. Antimicrobial prophylaxis 
Surgical  antimicrobial  prophylaxis  (AMP)  refers  to  a  very  brief  course  of  an 
antimicrobial agent initiated just before an operation begins.  AMP is not an attempt to sterilize 
tissues, but a critically timed adjunct used to reduce the microbial burden of intraoperative 
contamination  to  a  level  that  cannot  overwhelm  host  defences.  AMP does  not  pertain  to 
prevention of SSI caused by postoperative contamination. Intravenous infusion is the mode of 
AMP delivery used most often in modern surgical practice.  Essentially all confirmed AMP 
indications pertain to elective operations in which skin incisions are closed in the operating 
room. 
Four principles must be followed to maximize the benefits of AMP: 
• Use an AMP agent for all operations or classes of operations in which its use has been 
shown to reduce SSI rates based on evidence from clinical trials or for those operations after 
which incisional or organ/space SSI would represent a catastrophe. 
• Use an AMP agent that is safe, inexpensive, and bactericidal with an in vitro spectrum that 
covers the most probable intraoperative contaminants for the operation. 
• Time  the  infusion  of  the  initial  dose  of  antimicrobial  agent  so  that  a  bactericidal 
concentration of the drug is established in serum and tissues by the time the skin is incised. 
• Maintain therapeutic levels of the antimicrobial agent in both serum and tissues throughout 
the operation and until, at most, a few hours after the incision is closed in the operating 
room,  
Because clotted blood is present in all surgical wounds, therapeutic serum levels of AMP 
agents are logically important in addition to therapeutic tissue levels. Fibrin-enmeshed bacteria 
may be resistant to phagocytosis or to contact with antimicrobial agents that diffuse from the 
wound space. 
A simple  way  to  organize  AMP indications  is  based  on  using  the  surgical  wound 
classification  scheme  that  has  already  been  outlined  in  the  definitions,  which  employs 
descriptive  case  features  to  postoperatively  grade  the  degree  of  intraoperative  microbial 
contamination.  A surgeon makes  the  decision  to  use  AMP by anticipating  preoperatively  the 
surgical wound class for a given operation. 
AMP  is  indicated  for  all  operations  that  entail  entry  into  a  hollow  viscus  under 
controlled conditions. 
AMP is sometimes indicated for operations that entail incisions through normal tissue 
and in which no viscus is entered and no inflammation or infection is encountered. Two well-
recognized AMP indications for such clean operations are: 
a) When any intravascular prosthetic material or a prosthetic joint will be inserted, and 
b) For any operation in which an incisional or organ/space SSI would pose catastrophic risk. 
Some have advocated use of AMP during all operations on the breast. 
By definition, AMP is not indicated for an operation classified as contaminated or dirty. 
In  such  operations,  patients  are  frequently  receiving  therapeutic  antimicrobial  agents 
preoperatively for established infections. 
Cephalosporins are the most thoroughly studied AMP agents. These drugs are effective 
against many gram-positive and gram-negative micro-organisms. They also share the features 
of  demonstrated  safety,  acceptable  pharmacokinetics,  and  a  reasonable  cost  per  dose.  In 
particular, Cefazolin is widely used and generally viewed as the AMP agent of first choice for 
clean operations.  If a patient is unable to receive a cephalosporin because of penicillin allergy, 
an alternative for gram-positive bacterial coverage is either Clindamycin or Vancomycin. 
The  aminoglycosides  are  seldom  recommended  as  first  choices  for  antimicrobial 
prophylaxis, either as single drugs or as components of combination regimens.  The routine use 
of Vancomycin in AMP is not recommended for any kind of operation. However, Vancomycin 
may be the AMP agent of choice in certain clinical circumstances, such as when a cluster of 
MRSA  mediastinitis  or  incisional  SSI  due  to  Methicillin-resistant  coagulase-negative 
Staphylococci has been detected. 
Agents  most  commonly  used  for  AMP (i.e.,  cephalosporins)  exhibit  time-dependent 
bactericidal action. The therapeutic effects of such agents are probably maximized when their 
levels continuously exceed a threshold value best approximated by the minimal bactericidal 
concentration  value  observed  for  the  target  pathogens  in  vitro.  When  the  duration  of  an 
operation is expected to exceed the time in which therapeutic levels of the AMP agent can be 
maintained, additional AMP agent should be infused. That time point for Cefazolin is estimated 
as 3 to  4  hours. In general, the timing of a second (or third, etc.) dose of any AMP drug is 
estimated  from  three  parameters:  tissue  levels  achieved  in  normal  patients  by  a  standard 
therapeutic dose, the approximate serum half-life of the drug, and awareness of approximate 
MIC90 values for anticipated SSI pathogens. Basic "rules of thumb" guide decisions about AMP 
dose sizes and timing. 
For example, it is believed that a full therapeutic dose of cefazolin (1-2 g) should be 
given to adult patients no more than 30 minutes before the skin is incised. There are a few 
exceptions to this basic guide. With respect to dosing, it  has been demonstrated that larger 
doses of  AMP agents  are  necessary  to achieve optimum effect  in  morbidly  obese patients.  
Simple protocols of AMP timing and oversight responsibility should be locally designed to be 
practical and effective. 
Operative characteristics: Intraoperative issues
 a. Operating room environment 
(1) Ventilation 
Operating room air may contain microbial-laden dust, lint, skin squames, or respiratory 
droplets. The microbial level in operating room air is directly proportional to the number of 
people moving about in the room. Therefore, efforts should be made to minimize personnel 
traffic during operations. Outbreaks of SSIs caused by group A beta-haemolytic streptococci 
have  been traced to  airborne  transmission of  the  organism from colonized operating room 
personnel to patients.
 Operating rooms should be maintained at positive pressure with respect to corridors and 
adjacent areas. Positive pressure prevents airflow from less clean areas into more clean areas. 
All ventilation or air conditioning systems in hospitals, including those in operating rooms, 
should have two filter beds in series, with the efficiency of the first filter bed being 30% and 
that  of  the  second filter  bed  being 90%.  Conventional  operating  room ventilation  systems 
produce a minimum of about 15 air changes of filtered air per hour, three (20%) of which must 
be fresh air. Air should be introduced at the ceiling and exhausted near the floor.
 Laminar airflow and use of DV radiation have been suggested as additional measures to 
reduce SSI risk for certain operations. Laminar airflow is designed to move particle-free air 
(called  "ultra  clean air")  over  the  aseptic  operating field  at  a  uniform velocity  (0.3 to  0.5 
m/sec),  sweeping away particles  in  its  path.  Laminar  airflow can be directed  vertically  or 
horizontally. 
(2) Environmental surfaces 
It  is  important  to  perform routine  cleaning of  these  surfaces  to  re-establish  a  clean 
environment  after  each  operation.  There  are  no  data  to  support  routine  disinfecting  of 
environmental surfaces or equipment between operations in the absence of contamination or 
visible soiling. When visible soiling of surfaces or equipment occurs during an operation, an 
Environmental  Protection  Agency  (EPA)-approved  hospital  disinfectant  should  be  used  to 
decontaminate the affected areas before the next operation to reduce the risk of SSI. 
(3) Microbiologic sampling 
Because there are no standardized parameters  by which to compare microbial  levels 
obtained from cultures of ambient air or environmental surfaces in the operating room, routine 
microbiologic  sampling  cannot  be  justified.  Such  environmental  sampling  should  only  be 
performed as part of an epidemiologic investigation. 
(4) Conventional sterilization of surgical instruments 
Inadequate sterilization of surgical instruments has resulted in SSI outbreaks.   Surgical 
instruments  can  be  sterilized  by  steam under  pressure,  dry  heat,  ethylene  oxide,  or  other 
approved  methods.  The  importance  of  routinely  monitoring  the  quality  of  sterilization 
procedures  has  been  established.  Microbial  monitoring  of  steam autoclave  performance  is 
necessary and can be accomplished by use of a biological indicator. 
b. Surgical attire and drapes 
In this section the term  surgical attire  refers to scrub suits, caps/hoods, shoe covers, 
masks,  gloves,  and gowns. Although experimental data show that live micro-organisms are 
shed  from  hair,  exposed  skin,  and  mucous  membranes  of  operating  room personnel,  few 
controlled clinical studies have evaluated the relationship between the use of surgical attire and 
SSI risk. Nevertheless, the use of barriers seems prudent to minimize a patient's exposure to the 
skin, mucous membranes, or hair of surgical team members, as well as to protect surgical team 
members from exposure to blood and bloodborne pathogens (e.g., human immunodeficiency 
virus and hepatitis viruses). 
(1) Masks 
The  wearing  of  surgical  masks  during  operations  to  prevent  potential  microbial 
contamination of incisions is a longstanding surgical tradition. However,  some studies have 
raised questions about the efficacy and cost-benefit  of surgical masks in reducing SSI risk. 
Nevertheless, wearing a mask can be beneficial since it protects the wearer's nose and mouth 
from inadvertent exposures (i.e., splashes) to blood and other body fluids. 
(2) Surgical caps/hoods and shoe covers 
Surgical caps/hoods are inexpensive and reduce contamination of the surgical field by 
organisms  shed  from  the  hair  and  scalp.  SSI  outbreaks  have  occasionally  been  traced  to 
organisms isolated from the hair or scalp (Staph.  aureus  and group A Streptococcus),    even 
when caps were worn by personnel during the operation and in the operating suites. 
 (3) Sterile gloves 
Sterile gloves are put on after donning sterile gowns. 
A strong theoretical  rationale  supports  the wearing of  sterile  gloves  by all  scrubbed 
members of the surgical  team. Sterile  gloves are worn to minimize transmission of micro-
organisms from the hands of team members to patients and to prevent contamination of team 
members' hands with patients' blood and body fluids. If the integrity of a glove is compromised 
(e.g., punctured), it should be changed as promptly as safety permits.   Wearing two pairs of 
gloves (double-gloving) has been shown to reduce hand contact with patients' blood and body 
fluids when compared to wearing only a single pair.  
(4) Gowns and drapes 
Sterile surgical gowns and drapes are used to create a barrier between the surgical field 
and potential sources of bacteria. Gowns are worn by all scrubbed surgical team members and 
drapes are placed over the patient. 
c. Asepsis and surgical technique 
(1) Asepsis 
Rigorous  adherence  to  the  principles  of  asepsis  by  all  scrubbed  personnel  is  the 
foundation of surgical site infection prevention. Others who work in close proximity to the 
sterile surgical field, such as anaesthesia personnel who are separated from the field only by a 
drape barrier, also must abide by these principles. SSIs have occurred in which anaesthesia 
personnel  were  implicated  as  the  source  of  the  pathogen.   Anaesthesiologists  and  nurse 
anaesthetists  perform  a  variety  of  invasive  procedures  such  as  placement  of  intravascular 
devices and endotracheal tubes, and administration of intravenous drugs and solutions. Lack of 
adherence  to  the  principles  of  asepsis  during  such  procedures,  including  use  of  common 
syringes and contaminated infusion pumps and the assembly of equipment and solutions in 
advance  of  procedures,  have  been  associated  with  outbreaks  of  postoperative  infections, 
including SSI. Recommendations for infection control practices in anaesthesiology have been 
published.  
(2) Surgical technique 
Excellent  surgical  technique  is  widely  believed  to  reduce  the  risk  of  SSI.   Such 
techniques include maintaining effective haemostasis while preserving adequate blood supply, 
preventing hypothermia,  gently handling tissues,  avoiding inadvertent  entries  into a hollow 
viscus, removing devitalized (e.g., necrotic or charred) tissues, using drains and suture material 
appropriately, eradicating dead space, and appropriately managing the postoperative incision. 
Any  foreign  body,  including  suture  material,  a  prosthesis,  or  drain,  may  promote 
inflammation at the surgical site and may increase the probability of SSI after otherwise benign 
levels of tissue contamination. Extensive research compares different types of suture material 
and their presumed relationships to SSI risk.  In general, monofilament sutures appear to have 
the lowest infection-promoting effects.  
Drains  placed  through  an  operative  incision  increase  incisional  SSI  risk.  Many 
authorities  suggest  placing  drains  through  a  separate  incision  distant  from  the  operative 
incision. It appears that SSI risk also decreases when closed suction drains are used rather than 
open  drains.  Closed  suction  drains  can  effectively  evacuate  postoperative  haematomas  or 
seromas, but timing of drain removal is important.  Bacterial colonization of initially sterile 
drain tracts increases with the duration of time the drain is left in place. 
Operative Characteristics: Postoperative Issues 
a. Incision care 
The type of postoperative incision care is determined by whether the incision is closed 
primarily (i.e., the skin edges are re-approximated at the end of the operation), left open to be 
closed  later,  or  left  open  to  heal  by  second  intention.  When  a  surgical  incision  is  closed 
primarily, as most are, the incision is usually covered with a sterile dressing for 24 to 48 hours. 
Beyond 48 hours, it is unclear whether an incision must be covered by a dressing or whether 
showering or bathing is detrimental to healing. When a surgical incision is left open at the skin 
level for a few days before it is closed (delayed primary closure), a surgeon has determined that 
it is likely to be contaminated or that the patient's condition prevents primary closure (e.g., 
oedema at the site). When such is the case, the incision is packed with a sterile dressing. When 
a surgical incision is left open to heal by second intention, it is also packed with sterile moist 
gauze and covered with a sterile dressing. The American College of Surgeons, CDC, and others 
have  recommended  using  sterile  gloves  and  equipment  (sterile  technique)  when  changing 
dressings on any type of surgical incision. 
b. Discharge planning 
In current practice, many patients are discharged very soon after their operation, before 
surgical incisions have fully healed.  The lack of optimum protocols for home incision care 
dictates that much of what is done at home by the patient, family, or home care agency practi-
tioners must be individualized. The intent of discharge planning is to maintain integrity of the 
healing incision, educate the patient about the signs and symptoms of infection, and advise the 
patient about whom to contact to report any problems. 
SSI surveillance
Surveillance of SSI with feedback of appropriate data to surgeons has been shown to be 
an important component of strategies to reduce SSI risk. 
RECOMMENDATIONS FOR PREVENTION OF SURGICAL SITE 
INFECTION 
Rationale: 
The  Guideline  for  Prevention  of  Surgical  Site  Infection,  1999,  provides 
recommendations concerning reduction of surgical site infection risk. Each recommendation is 
categorized on the basis of existing scientific data, theoretical rationale, and applicability. 
Category   I  A.  Strongly  recommended for  implementation  and supported  by  well-designed 
experimental, clinical, or epidemiological studies. 
Category  I B. Strongly recommended for implementation and supported by some experimental, 
clinical, or epidemiological studies and strong theoretical rationale. 
Category  II.  Suggested  for  implementation  and  supported  by  suggestive  clinical  or 
epidemiological studies or theoretical rationale. 
No recommendation; unresolved issue. Practices for which insufficient evidence or no consensus 
regarding efficacy exists. 
Recommendations: 
1. Preoperative 
a. Preparation of the patient 
1. Whenever possible, identify and treat all infections remote to the surgical site before elective 
operation and postpone elective operations on patients  with remote site  infections until  the 
infection has resolved. Category IA 
2. Do not remove hair preoperatively unless the hair at or around the incision site will interfere 
with the operation. Category IA 
3.  If  hair  is  removed,  remove  immediately  before  the  operation,  preferably  with  electric 
clippers. Category IA 
4. Adequately control serum blood glucose levels in all diabetic patients and particularly avoid 
hyperglycaemia perioperatively. Category IB 
5. Encourage tobacco cessation. At minimum, instruct patients to abstain for at least 30 days 
before elective operation from smoking cigarettes, cigars, pipes, or any other form of tobacco 
consumption (e.g., chewing/dipping). Category IB 
6. Do not withhold necessary blood products from surgical patients as a means to prevent SSIs. 
Category IB 
7. Require patients to shower or bathe with an antiseptic agent on at least the night before the 
operative day. Category IB 
8. Thoroughly wash and clean at and around the incision site to remove gross contamination 
before performing antiseptic skin preparation. Category IB 
9. Use an appropriate antiseptic agent for skin preparation. Category IB 
10.  Apply preoperative  antiseptic  skin preparation in  concentric  circles  moving toward  the 
periphery.  The  prepared  area  must  be  large  enough  to  extend  the  incision  or  create  new 
incisions or drain sites, if necessary. Category II 
11.  Keep  preoperative  hospital  stay  as  short  as  possible  while  allowing  for  adequate 
preoperative preparation of the patient. Category II 
12.  No  recommendation  to  taper  or  discontinue  systemic  steroid  use  (when  medically 
permissible) before elective operation. Unresolved issue 
13. No recommendation to enhance nutritional support for surgical patients solely as a means to 
prevent SSIs. Unresolved issue 
14. No recommendation to preoperatively apply mupirocin to nares to prevent SSIs. Unresolved  
issue 
15. No recommendation to provide measures that enhance wound space oxygenation to prevent 
SSIs. Unresolved issue 
b. Hand/forearm antisepsis for surgical team members 
1. Keep nails short and do not wear artificial nails. 
Category IB 
2.  Perform a  preoperative  surgical  scrub  for  at  least  2  to  5  minutes  using  an  appropriate 
antiseptic. Scrub the hands and forearms up to the elbows. Category IB 
3. After performing the surgical scrub, keep hands up and away from the body (elbows in 
flexed position) so that water runs from the tips of the fingers toward the elbows. Dry hands 
with a sterile towel and don a sterile gown and gloves. Category IB 
4.  Clean underneath each fingernail  prior to performing the first surgical scrub of the day. 
Category II 
5. Do not wear hand or arm jewellery. Category 11 
6. No recommendation on wearing nail polish. 
Unresolved Issue 
c. Management of infected or colonized surgical personnel 
1. Educate and encourage surgical personnel who have signs and symptoms of a transmissible 
infectious illness to report conditions promptly to their supervisory and occupational health 
service personnel. Category IB 
2. Develop well-defined policies concerning patient care responsibilities when personnel have 
potentially  transmissible  infectious  conditions.  These  policies  should  govern  (a)  personnel 
responsibility in using the health service and reporting illness, (b) work restrictions, and (c) 
clearance  to  resume work after  an  illness  that  required  work  restriction.  The  policies  also 
should identify persons who have the authority to remove personnel from duty. Category IB 
3.  Obtain  appropriate  cultures  from,  and  exclude  from duty,  surgical  personnel  who  have 
draining skin lesions until infection has been ruled out or personnel have received adequate 
therapy and infection has resolved. Category IB 
4.  Do not  routinely  exclude surgical  personnel  who are  colonized  with organisms such as 
Staph.  aureus (nose, hands, or other body site) or group A Streptococcus, unless such personnel 
have been linked epidemiologically to dissemination of the organism in the healthcare setting. 
Category IB 
d. Antimicrobial prophylaxis 
1. Administer a prophylactic antimicrobial agent only when indicated, and select it based on its 
efficacy against the most common pathogens causing SSI for a specific operation and published 
recommendations. Category lA 
2.  Administer by the intravenous route the initial  dose of  prophylactic antimicrobial  agent, 
timed such that a bactericidal concentration of the drug is established in serum and tissues 
when  the  incision  is  made.  Maintain  therapeutic  levels  of  the  agent  in  serum and  tissues 
throughout the operation and until,  at  most,  a few hours after the incision is closed in the 
operating room. Category lA 
3.  Before  elective  colorectal  operations  in  addition  to  the  above,  mechanically  prepare  the 
colon  by use  of  enemas  and cathartic  agents.  Administer  nonabsorbable  oral  antimicrobial 
agents in divided doses on the day before the operation. Category lA 
4.  For  high-risk  Caesarean  section,  administer  the  prophylactic  antimicrobial  agent 
immediately after the umbilical cord is clamped. Category lA 
5. Do not routinely use Vancomycin for antimicrobial prophylaxis. Category IB 
2. Intraoperative 
a. Ventilation 
1. Maintain positive-pressure ventilation in the operating room with respect to the corridors and 
adjacent areas. Category IB 
2. Maintain a minimum of 15 air changes per hour, of which at least 3 should be fresh air.  
Category IB 
3. Filter all air, re circulated and fresh, through the appropriate filters per the American Institute 
of Architects' recommendations. Category IB 
4. Introduce all air at the ceiling, and exhaust near the floor. Category IB 
5. Do not use DV radiation in the operating room to prevent SSIs. Category IB 
6. Keep operating room doors closed except as needed for passage of equipment, personnel, 
and the patient. Category IB 
7. Consider performing orthopaedic implant operations in operating rooms supplied with ultra 
clean air. Category 11 
8. Limit the number of personnel entering the operating room to necessary personnel. Category 
II 
b. Cleaning and disinfection of environmental surfaces 
1.  When  visible  soiling  or  contamination  with  blood  or  other  body  fluids  of  surfaces  or 
equipment occurs during an operation, use an EPA-approved hospital disinfectant to clean the 
affected areas before the next operation. Category IB  
2. Do not perform special cleaning or closing of operating rooms after contaminated or dirty 
operations. Category IB 
3. Do not use tacky mats at the entrance to the operating room suite or individual operating 
rooms for infection control. Category IB 
4.  Wet-vacuum the operating room floor after the last operation of the day or night with an 
EPA-approved hospital disinfectant. Category II 
5. No recommendation on disinfecting environmental surfaces or equipment used in operating 
rooms between operations in the absence of visible soiling. Unresolved issue  
c. Microbiologic sampling 
1.  Do  not  perform  routine  environmental  sampling  of  the  operating  room.  Perform 
microbiologic sampling of operating room environmental surfaces or air only as part  of an 
epidemiologic investigation. Category IB 
d. Sterilization of surgical instruments 
1. Sterilize all surgical instruments according to published guidelines. Category IB 
2. Perform flash sterilization only for patient care items that will be used immediately (e.g., to 
reprocess an inadvertently dropped instrument). Do not use flash sterilization for reasons of 
convenience,  as  an  alternative  to  purchasing  additional  instrument  sets,  or  to  save  time. 
Category IB 
e. Surgical attire and drapes 
1. Wear a surgical mask that fully covers the mouth and nose when entering the operating room 
if an operation is about to begin or already under way, or if sterile instruments are exposed. 
Wear the mask throughout the operation. Category IB 
2.  Wear a cap or hood to fully cover hair on the head and face when entering the operating 
room. Category IB  
3. Do not wear shoe covers for the prevention of SSIs 
Category IB  
4. Wear sterile gloves if a scrubbed surgical team member. Put on gloves after donning a sterile 
gown. Category IB  
5. Use surgical gowns and drapes that are effective barriers when wet (i.e., materials that resist  
liquid penetration). Category IB 
6. Change scrub suits that are visibly soiled, contaminated, and/or penetrated by blood or other 
potentially infectious materials. Category IB.
7. No recommendations on how or where to launder scrub suits, on restricting use of scrub suits 
to the operating suite, or for covering scrub suits when out of the operating suite.  Unresolved 
issue 
f. Asepsis and surgical technique 
1.  Adhere  to  principles  of  asepsis  when placing intravascular  devices  (e.g.,  central  venous 
catheters),  spinal  or  epidural  anaesthesia  catheters,  or  when  dispensing  and  administering 
intravenous drugs. Category IA 
2. Assemble sterile equipment and solutions immediately prior to use. Category II 
3. Handle tissue gently, maintain effective haemostasis, minimize devitalized tissue and foreign 
bodies (i.e., sutures, charred tissues, necrotic debris), and eradicate dead space at the surgical 
site. Category IB 
4. Use delayed primary skin closure or leave an incision open to heal by second intention if the 
surgeon considers the surgical site to be heavily contaminated (e.g., Class III and Class IV). 
Category IB 
5. If drainage is necessary, use a closed suction drain. Place a drain through a separate incision 
distant from the operative incision. Remove the drain as soon as possible. Category IB 
3. Postoperative incision care 
a. Protect with a sterile dressing for  24  to  48  hours postoperatively an incision that has been 
closed primarily. Category IB 
b. Wash hands before and after dressing changes and any contact with the surgical site. Category  
IB 
c. When an incision dressing must be changed, use sterile technique. Category II 
d. Educate the patient and family regarding proper incision care, symptoms of SSI, and the 
need to report such symptoms. Category II 
e.  No recommendation  to  cover  an incision  closed  primarily  beyond  48  hours,  nor  on the 
appropriate time to shower or bathe with an uncovered incision. Unresolved Issue 
4. Surveillance 
a.  Use  CDC definitions  of  SSIs without  modification  for  identifying  SSI  among  surgical 
inpatients and outpatients. Category IB 
b.  For  inpatient  case-finding  (including  readmissions),  use  direct  prospective  observation, 
indirect prospective detection, or a combination of both direct and indirect methods for the 
duration of the patient's hospitalization. Category IB 
c. When post-discharge surveillance is performed for detecting SSI following certain operations 
(e.g., coronary artery bypass graft), use a method that accommodates available resources and 
data  needs.  
Category II 
d. For outpatient case-finding, use a method that accommodates available resources and data 
needs. Category IB 
e. Assign the surgical wound classification upon completion of an operation. A surgical team 
member should make the assignment. Category II 
f.  For each patient undergoing an operation chosen for  surveillance,  record those variables 
shown to be associated with increased SSI risk (e.g.,  surgical wound class,  ASA class, and 
duration of operation). Category IB 
AIM
After having reviewed the extensive amount of literature on the subject of Surgical Site 
Infections, the aim of the study was formulated keeping in mind the limitations of the set-up.
This  is  a  descriptive  study  of  superficial  SSIs  in  clean  surgeries  with  pre-operative 
antibiotic  prophylaxis  using  intravenous  Cefotaxime  and  intravenous  Ampicillin  with  the 
following objectives:
 To document the frequency of surgical site infections in cases of clean surgeries in our 
surgical unit.
 To compare the rates of infection with each of the two drugs used.
 To observe the rates of infection in men and women undergoing surgeries.
 To document the duration of stay of the patients included in the study and to compare 
the length of stay of the patients who developed SSIs with that of those who didn’t.
 To study the cost of treatment incurred. 
MATERIALS AND METHODS
A descriptive study was conducted in Govt. Stanley Hospital in our Surgical Unit from 
June 2003 to May 2005. Selection and exclusion criteria were laid out.
Patients between the ages of 15 and 70 years were selected. At one extreme, paediatric 
physiology  differs  considerably  from  adult  physiology  especially  in  the  way  the  body 
metabolized drugs and so, dosages differ. At the other extreme, people older than 70years of 
age are at a higher risk for SSIs due to various reasons.
Diagnoses, which involved clean surgeries as treatment, were selected.
Any  patients  for  whom  perineal  exploration  was  required  (hydroceles,  etc)  were 
excluded from the study due to high microbial contamination of the perineal skin and therefore, 
higher risk of infection.
Any procedure, which involved entry into body cavities or manipulation of viscera, was 
excluded – these are, by definition, not clean procedures.
Re-operative surgery  was excluded. 
Poor blood supply and vascularisation in the scar tissue due to the previous surgery puts 
the wound at risk of delayed healing and therefore, increased risk of infection.
Incisional hernias, which form a sizeable chunk of the number of cases requiring re-
operation, were excluded. One of the cardinal risk-factors for development of these hernias is 
wound infection and so, incisional hernias by definition can’t be regarded as clean cases.
Smoking habits of patients were taken into account.  However, the ubiquitous practice of 
smoking  and  high  percentage  of  smokers,  especially  among the  male  population,  made  it 
difficult to exclude patients on this basis.  We would have had substantially fewer patients in  
the group. 
An intact immune status is essential for combating infection. So, immuno-compromised 
states put patients at a higher risk for infection. Conditions like diabetes, malignancy, steroid 
administration and malnutrition, which compromise the immunity of the body, were considered 
and therefore, patients with these diseases were excluded.  
Nutritional status of the patients was assessed with the help of weight of patient, height 
in metres and Quetelet’s BMI. This was used to exclude the undernourished and overnourished 
patients.
History of Allergy was considered
EXCLUSION CRITERIA
 Age below 15 years and over 70 years
 Perineal lesions (Hydroceles, lumps and bumps over perineal skin, etc.)
 Diabetes mellitus
 Malignancy
 Steroid usage (asthmatics, etc.)
 Malnutrition  (BMI < 20)
 Obesity (BMI > 30).
 Re-operative surgeries and including incisional hernias.
 Patients already on antibiotics for other causes.
CASES INCLUDED
Clean Surgeries – Inguinal hernias, benign conditions of the female and male breast, 
thyroid surgery, parotid and submandibular surgery excision of lumps and bumps over skin. 
Once the patients were selected based on the above criteria, the date of admission was 
planned in such a way that the patients got admitted one or two days prior to the date of  
surgery.
The antibiotics to be used were assigned randomly after checking allergy with the help 
of a test dose on the day before surgery. 
Each patient was to be administered 1g of Ampicillin or Cefotaxime intravenously on 
the morning of the surgery within 2 hours prior to the time of incision. 
Provisions and protocols  were  placed for  usage of  alternative  drugs in  case  of  drug 
allergy, which was tested with an intradermal dose of the drug on the day prior to the surgery. If 
found allergic to Ampicillin, the patient was to be given Cefotaxime. In case of Cefotaxime 
allergy, the patient was to be given Ciprofloxacin, two available drugs in this hospital. 
The skin was prepared on the day of surgery.
The first prophylactic dose of antibiotic was given pre-operatively via the intravenous 
route.
The duration of surgery was noted.
Attention was given to tissue handling, haemostasis, dead space obliteration, removal of 
devitalised tissue and operating time.
Top-up dose of the same antibiotic was given 3 hours after incision in case the surgery 
took longer than 3hours.
The postoperative course and recovery was observed.
Date of suture removal was noted.
After discharge, each patient was followed-up weekly for the first 1 month.
In cases warranting surveillance for longer, monthly follow-up was done after the first month 
upto a period of 1 year.
The results were then tabulated.
OBSERVATIONS AND RESULTS
A total of 114 patients were included in the study, out of which 57 were men and 57 
were ladies.  
Intravenous  Cefotaxime  was  used  in  54  of  the  114  cases,  while  intravenous 
Ampicillin was used in 60 patients.
Inguinal herniorrhaphy for groin hernias was the most frequently performed surgery. 
Other surgeries done have been shown in the graph below:
Out of the patients, 12 patients developed SSIs, the diagnosis of which was made in 
accordance  with  the  CDC guidelines  for  prevention  of  SSIs.  The  Cefotaxime arm and 
Ampicillin arm had 6 cases of SSIs each.  No patient developed drug allergy to either of the 
drugs used. 
Overall,  12 patients  out of  the total  of 114 developed surgical  site  infections,  an 
incidence of 10.5 %( 95% C.I. 5.8% – 17.2%).
In the Cefotaxime arm, 6 out of 54 patients developed SSIs (incidence rate 11.1%) 
while in the Ampicillin arm, 6 out of 60 patients developed SSIs (incidence of 10.0%). The 
difference of 1.1% wasn’t statistically significant (p=1.0).
Out of 57 male patients included, 7 developed SSIs (incidence of 12%) and out of 
the 57 female patients in the study, 5 developed SSIs (incidence of 8.8%). This difference 
was insignificant as well.
The  average  duration  of  hospital  stay  was  5.4  days  in  the  non-infected  group, 
compared to 9.6 days in the infected group.
The cost for 1g of Ampicillin was Rs.15, while the cost for 1g of Cefotaxime was 
Rs.40.
DISCUSSION
In the study conducted,  the rate of surgical  site  infections was    10.5% overall,  as 
already mentioned.  As far as  our hospital  is concerned,  there was no significant difference 
between the usage of Ampicillin  and Cefotaxime,  even though from references worldwide,  
Ampicillin  is  believed  to  be  no  longer  active  against  Staph.  aureus,  presumably  the  most 
common pathogen implicated in superficial SSIs.
The length of stay in hospital was significantly higher in cases that developed SSIs, 
which justifies the practice of pre-operative antibiotic prophylaxis.
The cost of Cefotaxime is almost thrice that of Ampicillin. Also, usage of Cefotaxime 
doesn’t appear to confer any specific advantage as far as risk of SSI is concerned. In our set-up, 
in which the establishment bears the cost of treatment in the vast majority of patients, this is a 
very significant observation. Judicious use of a particular drug will potentially save a lot of 
expenditure to the exchequer.  
However, the overall incidence of SSIs is much higher than the world standard of 2-5%. 
Various factors have influenced the high rate of infection.
1) Firstly,  the atmosphere  and environment prevalent in  this  part  of  the  world is  a  big 
influence on infection, with the ambient temperature hovering around 33oC – 38oC all the 
year round. The  humidity in the air approaches 85-90% for most part of the year.  As a 
result, the skin is warm and moist, very much favouring bacterial proliferation.
2) In  the  study  conducted,  the  majority  of  subjects  come from the  lower  strata  of  the 
socioeconomic ladder.  As a result, patient awareness about the need for hygiene is low, 
increasing the risk of bacterial contamination of the skin and hence of the wound.
3) From the literature reviewed, it is evident that smoking increases the risk of infection 
significantly.   Tobacco smoke  contains  metalloproteinases  among its  5000 constituents. 
These cause breakdown of structural proteins like collagen, thus hindering the process of 
fibrosis in a wound.  This increase chances of developing a wound infection.  Smoking as a 
habit is ubiquitous among the patients of this hospital, especially the males.  Regardless of 
the attempts of health care personnel to educate the patients about the ill-effects of smoking 
and the required precautions to be taken, there lies a serious question mark as regards to 
patient compliance in this respect.
4) Pre-operative colonization of nares with Staphylococci, which is an important promoter 
of infections, is widespread.
5) \The system of ventilation of the operating room is less than ideal in this set up.  This is  
another important determinant of the rate of surgical site infections.
6) Last, but definitely not the least, lies the role of the surgeon.  The face off of reliable  
experience versus youthful exuberance has been, is and will forever be a topic of raging 
controversy and contradiction.
Surgery is, after all, an art which can only be imbibed with diligent practice. After all,  
one can only lead the horse to the waterhole.  Obviously, the learning curve will come into 
consideration.   Gentle handling of tissues,  reduction of dead space, maintenance of perfect 
haemostasis, complete removal of devitalised tissue and operating time are some aspects of 
surgery which have to be perfected with time.  In letting the youngsters learn, the experienced 
teachers show immense magnanimity.  Inherent adverse effects necessary disadvantages of this 
process are exemplified by the high infection rate, the price mankind pays.
CONCLUSIONS
 In the study conducted, the rate of surgical site infections was    10.5% overall, as already 
mentioned. 
 As far as our hospital is concerned, there was no significant difference between the usage of 
Ampicillin and Cefotaxime. 
 The length of stay in hospital was significantly higher in cases that developed SSIs, which 
justifies the practice of pre-operative antibiotic prophylaxis.
 The cost  of  Cefotaxime is  almost  thrice  that  of  Ampicillin.  Also,  usage of  Cefotaxime 
doesn’t appear to confer any specific advantage as far as risk of SSI is concerned. 
 In our set-up, in which the establishment bears the cost of treatment in the vast majority of  
patients, this is a very significant observation.
 Judicious use of a particular drug will potentially save a lot of expenditure to the exchequer. 
PROFORMA
Name : Age/Sex:         IP No.:
Height / Weight: BMI :
Diagnosis :
Past Medical History especially :
Diabetic : Yes / No
Malignancy : Yes / No
Hypertension
Previous Surgeries if any:
History of Allergy :
Drug history - Long-term medications, especially corticosteroids.
Date of Admission :
Date of Surgery :
Details :
Tissue Handling :
Duration of Surgery :
Haemostasis :
Dead space obliteration :
Antibiotic given :
Allergic reaction to test dose:
Time of administration :
Any additional dose given :
Post-operative course :
Dose of Suture removal :
Date of discharge :
Follow-up :
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